treatment of gastroenteropancreatic neuroendocrine tumors
All entries for: RayzeBio, Inc.
August 26, 2026
RayzeBio, Inc.
Orphan Drug Designation
San Diego
1-50 employees
Disease Area: Rare Disease
treatment of gastroenteropancreatic neuroendocrine tumors